NCT07029841 Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong
| NCT ID | NCT07029841 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Pulmonary Embolism Acute |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2022-06-01 |
| Primary Completion | 2032-12-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2022-06-01 with a primary completion date of 2032-12-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This retrospective cohort study (Hong Kong PECT Registry) compares treatment outcomes between different percutaneous catheter-based therapies in patients with acute pulmonary embolism (PE). PE is a critical condition with potential for rapid deterioration and mortality before treatment. While availability of catheter-based therapy contributed to the declining mortality rates of PE, selecting the appropriate intervention remains key. There are primarily two modes of therapies available: Catheter-directed thrombolysis and Aspiration thrombectomy (e.g., Penumbra, Flowtriever, AlphaVac) Given limited direct comparisons between these methods, the study will evaluate their efficacy, safety, and clinical outcomes of these treatment strategies in acute PE patients.
Eligibility Criteria
Inclusion Criteria: * Patients who is admitted with a diagnosis of acute pulmonary embolism * Patient who receives any types of catheter-based therapy for acute pulmonary embolism. Exclusion Criteria: * nil. This is a all-comer registry.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07029841 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Embolism Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07029841 currently recruiting?
Yes, NCT07029841 is actively recruiting participants. Contact the research team at gtan@cuhk.edu.hk for enrollment information.
Where is the NCT07029841 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07029841 clinical trial?
NCT07029841 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 1,000 participants.